MRVL · Marvell Technology

The thesis

Marvell Technology shares are more likely to lag the S&P 500 than lead it over the next three months. Merger arbitrage traders give the $115 billion all-stock Lumentum deal only even odds, and Marvell does not expect it to close until the first half of 2028. The fiscal third-quarter report on 1 December 2026 shows whether fourth-quarter guidance and detail on how much the deal adds to earnings per share can offset that overhang.

Bloomberg reported on 9 November 2026 that the closing probability implied by merger arbitrage was near 50%. Bloomberg Intelligence's Jennifer Rie named China's regulatory review as the main risk to timing. Since then the shares have moved with the chip sector, not with deal news. Benzinga reported that Marvell rose more than 9% on 11 November 2026, when CoreWeave's third-quarter beat lifted AI stocks. Adjusted daily closes show $154.39 on 10 November 2026, $168.80 on 11 November 2026 and $164.45 on 12 November 2026.

The price reflects a deal priced as a coin flip and the dilution brokers modelled after it. Marvell closed at $164.45 on 12 November 2026, 50.1% below its 52-week high of $329.88 set on 18 June 2026, and the shares are down 25.9% over three months. The rating is Low because the deal overhang has a long horizon and nothing since the announcement has narrowed the odds. A sustained sector rebound is the main way the view fails.

On 12 November 2026 Marvell expanded its board to 10 directors from 7. It added Intuit Chairman and CEO Sasan Goodarzi, Lam Research CFO Douglas Bettinger and Walmart Chief People Officer Donna Morris. The company's release does not mention the Lumentum deal.

Bullish and bearish views on Marvell Technology, Inc.

The bull case on Marvell Technology, Inc. (MRVL), in brief: preliminary revenue confirms the guide. The bear case: arbitrage traders price a coin flip.

Bull case

• Preliminary revenue confirms the guide. Marvell said on 2 November 2026 that fiscal Q3 2027 revenue was consistent with guidance. It kept the $3.150 billion midpoint and narrowed the range to plus or minus 2%, so the 1 December 2026 report should hold few revenue surprises.
• Management and Cantor see accretion. Marvell's 2 November 2026 release says the deal will add to adjusted earnings per share in the first year after closing, with more than $1 billion of annual run-rate cost savings. Cantor Fitzgerald modelled calendar 2028 pro forma adjusted earnings per share of $12.55, against $12.50 for Marvell alone, Benzinga reported on 3 November 2026.
• Long-range targets still stand. At its 6 October 2026 Investor Day, Marvell set a fiscal 2031 revenue target of $70 billion to $90 billion. It raised its fiscal 2028 target to $20 billion from $18 billion.
• AI demand still lifts the group. CoreWeave rose 23% on 11 November 2026 after a third-quarter beat, and 16 other AI stocks gained more than 10% that day, Benzinga reported. Marvell's 9.3% gain in adjusted closes that session shows the shares still respond to AI spending news.
• Board adds chip-finance experience. Douglas Bettinger, who joined on 12 November 2026, is Lam Research's CFO and held finance roles at Avago/Broadcom, Xilinx and Intel, the company said. He joins the audit committee as Marvell works through a $115 billion merger.
• Some brokers keep Buy ratings. B. Riley Securities kept its Buy rating on 9 November 2026 and cut its target to $250 from $275, Benzinga and Fiscal.ai reported.

Bear case

• Arbitrage traders price a coin flip. Bloomberg reported on 9 November 2026 that the implied probability of closing was about 50%. A $3.2 billion reverse termination fee applies if regulators block the deal, Benzinga reported on 3 November 2026.
• The overhang runs into 2028. The deal needs both stockholder votes and regulatory approval, with closing expected in the first half of calendar 2028. The fixed ratio of 4.500 Marvell shares per Lumentum share ties the two prices together until then.
• Bank of America models dilution. Vivek Arya cut Marvell to Neutral and his target to $225 from $400 after the 2 November 2026 announcement, Benzinga reported. Without revenue synergies, his model puts earnings per share 4.9% below standalone in calendar 2028, 10.5% in 2029 and 14.7% in 2030.
• Analysts expect a long stall. Cantor's C.J. Muse cut his target to $225 from $350 and expects five to seven quarters of "deal purgatory," Benzinga reported on 3 November 2026. TD Cowen cut Marvell to Hold with a $175 target, down from $350, Stocktwits reported.
• Insiders sell on schedule; none buy. SEC Form 4 filings show President and COO Chris Koopmans sold 10,000 shares at $186.97 on 2 November 2026 and CEO Matt Murphy sold 7,500 at $235.47 on 15 October 2026, both under Rule 10b5-1 plans. No open-market purchase appears in the Form 4 filings from 1 October to 12 November 2026.

Price setup

The 5 November 2026 close of $133.55 is the low of the post-deal decline. The rebound reached $168.80 on 11 November 2026, and the shares closed at $164.45 on 12 November 2026. That close is below both the 50-day average of adjusted closes, $230.22, and the 200-day average, $186.55, as of 12 November 2026.

The 200-day average is the nearer level above the price. A close back over it would be the first sign that the post-deal decline has reversed. The 50-day average marks the level the shares held before the late-October selloff. The 52-week closing low of $73.73 on 4 February 2026 shows how far the shares rose before the deal.

The two dated events before the next published results are Nvidia's report on 17 November 2026 and Marvell's own report on 1 December 2026. The sector moved the shares on 5 November 2026 and again on 11 November 2026, and the Nvidia report is the next sector test.

Catalysts ahead

• 17 November 2026: Nvidia fiscal Q3 2027 report, with results at about 1:20 p.m. Pacific Time and the call at 2 p.m. Pacific Time. Nvidia guided to $108.0 billion of revenue, plus or minus 2%, for the quarter ended 25 October 2026. Its outlook sets the direction for AI chip stocks, which have moved Marvell more than deal news since 2 November 2026.
• 1 December 2026: Marvell fiscal Q3 2027 results, with the conference call at 1:30 p.m. Pacific Time. Revenue is largely known from the 2 November 2026 preliminary statement. Fiscal Q4 guidance, gross margin against the 57.5% low end and detail on earnings accretion from the deal decide whether results can offset the merger overhang.

What would change the view

A daily close above $231.06, just over the 50-day average of adjusted closes as of 12 November 2026, would show the shares leading the S&P 500 and prove this call wrong. So would a fiscal 2028 revenue target raised above the $20 billion set on 6 October 2026.

What it trades with

Marvell trades with Lumentum through the fixed 4.500 exchange ratio, and deal news moves both. Lumentum rose nearly 9% on 11 November 2026, the same session as Marvell's gain, Benzinga reported. Nvidia holds Series A convertible preferred stock in Marvell and sets the direction of AI chip stocks. Benzinga reported on 9 November 2026 that a board probe involving Jensen Huang left Nvidia at its most oversold level since 2019, and on 12 November 2026 that the matter had widened. Alphabet holds a warrant whose vesting depends on custom chip purchases. Since the deal was announced, sector moves, including the 5 November 2026 chip selloff and the 11 November 2026 AI rally, have set Marvell's direction more than company news.